| 1 | GALLSTONE DISEASE: EPIDEMIOLOGY, RISK FACTORS, CLINICAL FEAT… (10.20514/2226-6704-2016-6-3-30-35) | Abstract References ORCID License | 125.53 | 17 |
| 2 | REMAXOL: MECHANISMS OF ACTION AND APPLICATION IN REAL CLINIC… (10.20514/2226-6704-2016-6-2-16-21) | Abstract References ORCID License | 123.04 | 16 |
| 3 | BONE REMODELING IN NORM AND IN PRIMARY OSTEOPOROSIS: THE SIG… (10.20514/2226-6704-2018-8-2-100-110) | Abstract References ORCID License | 123.04 | 16 |
| 4 | HYPERAMMONIUM IN PATIENTS WITH PRECIRRHOSIS STAGE: CLINICAL… (10.20514/2226-6704-2018-8-3-186-193) | Abstract References ORCID License | 114.61 | 13 |
| 5 | CURRENT CONCEPT OF HUMAN HERPESVIRUS TYPE 6 INFECTION (10.20514/2226-6704-2016-6-1-13-19) | Abstract References ORCID License | 107.92 | 11 |
| 6 | REMAXOL: MECHANISMS OF ACTION AND APPLICATION IN REAL CLINIC… (10.20514/2226-6704-2016-6-3-8-18) | Abstract References ORCID License | 100.00 | 9 |
| 7 | PREVALENCE OF ARTERIAL HYPERTENSION AND RISK FACTORS IN YOUN… (10.20514/2226-6704-2017-7-1-30-34) | Abstract References ORCID License | 100.00 | 9 |
| 8 | ALGORITHM FOR THE TREATMENT OF PATIENTS WITH CHRONIC HEART F… (10.20514/2226-6704-2018-8-2-85-99) | Abstract References ORCID License | 100.00 | 9 |
| 9 | THE USE OF SPECIFIC AND NON-SPECIFIC QUESTIONNAIRES TO ASSES… (10.20514/2226-6704-2016-6-4-53-57) | Abstract References ORCID License | 95.42 | 8 |
| 10 | GROUND GLASS OPACITIES ON CT OF THE CHEST IN THE PRACTICE OF… (10.20514/2226-6704-2018-8-3-165-175) | Abstract References ORCID License | 95.42 | 8 |
| 11 | FEATURES OF PNEUMONIA IN HIV-INFECTED PATIENTS (10.20514/2226-6704-2016-6-1-71-76) | Abstract References ORCID License | 90.31 | 7 |
| 12 | IGG4-RELATED DISEASE: CONDITION OF THE PROBLEM (10.20514/2226-6704-2017-7-2-95-106) | Abstract References ORCID License | 90.31 | 7 |
| 13 | MYOCARDIAL INFARCTION TYPE 2. MYTH OR REALITY? (10.20514/2226-6704-2016-6-2-34-41) | Abstract References ORCID License | 84.51 | 6 |
| 14 | SUBCLINICAL LESION OF CAROTID ARTERIES IN CHRONIC GLOMERULON… (10.20514/2226-6704-2017-7-4-300-305) | Abstract References ORCID License | 84.51 | 6 |
| 15 | TREATMENT OF PERIPARTUM CARDIOMYOPATHY (REVIEW) (10.20514/2226-6704-2017-7-5-340-349) | Abstract References ORCID License | 84.51 | 6 |
| 16 | AGE AND GENDER PECULIARITIES OF DEVELOPMENT OF GALLSTONE DIS… (10.20514/2226-6704-2016-6-1-34-39) | Abstract References ORCID License | 77.82 | 5 |
| 17 | ASSESSMENT OF BIOLOGICAL AGE AND RATE OF AGING OF PATIENTS W… (10.20514/2226-6704-2017-7-4-287-291) | Abstract References ORCID License | 77.82 | 5 |
| 18 | CLINICAL SIGNS OF CHEMOTHERAPY-INDUCED NEUROPATHY IN CANCER… (10.20514/2226-6704-2018-8-2-137-144) | Abstract References ORCID License | 77.82 | 5 |
| 19 | LYELL`S SYNDROME. PRACTICAL CASE (10.20514/2226-6704-2018-8-3-231-236) | Abstract References ORCID License | 77.82 | 5 |
| 20 | ACTUAL METHODS’ OF DIAGNOSIS AND TREATMENT ARVI (10.20514/2226-6704-2016-6-1-6-12) | Abstract References ORCID License | 69.90 | 4 |
| 21 | CAMERON LESIONS: LITERATURE REVIEW AND CASE PRESENTATION (10.20514/2226-6704-2016-6-6-72-78) | Abstract References ORCID License | 69.90 | 4 |
| 22 | THE MODERN VIEW OF THE PATHOGENESIS AND LABORATORY DIAGNOSTI… (10.20514/2226-6704-2017-7-4-252-259) | Abstract References ORCID License | 69.90 | 4 |
| 23 | FEATURES OF AN INFECTIOUS ENDOCARDITIS IN INJECTION «SALT» A… (10.20514/2226-6704-2017-7-4-267-270) | Abstract References ORCID License | 69.90 | 4 |
| 24 | ANALYSIS OF EMERGENCY AMBULANCE RECALLS AMONG PATIENTS WITH… (10.20514/2226-6704-2017-7-5-358-363) | Abstract References ORCID License | 69.90 | 4 |
| 25 | SOME EPIDEMIOLOGICAL ASPECTS ASSOCIATED WITH INFECTIONS TRAN… (10.20514/2226-6704-2017-7-6-423-432) | Abstract References ORCID License | 69.90 | 4 |
| 26 | FORECASTING CORONARY EVENTS BASED ON THE ANALYSIS OF THE DYN… (10.20514/2226-6704-2018-8-1-36-44) | Abstract References ORCID License | 69.90 | 4 |
| 27 | PHARMACOGENETIC FEATURES OF THERAPY OF PATIENTS WITH ATHEROS… (10.20514/2226-6704-2018-8-1-45-52) | Abstract References ORCID License | 69.90 | 4 |
| 28 | THE MECHANISMS OF THE DISORDERS OF MOTOR-EVACUATION FUNCTION… (10.20514/2226-6704-2018-8-1-53-58) | Abstract References ORCID License | 69.90 | 4 |
| 29 | TRANSIENT GLOBAL AMNESIA IN A PATIENT WITH HYPERTENSIVE CRIS… (10.20514/2226-6704-2018-8-1-77-80) | Abstract References ORCID License | 69.90 | 4 |
| 30 | ASSESSMENT OF RELATED ANAMNESTIC AND CLINICAL FACTORS ON EFF… (10.20514/2226-6704-2016-6-1-29-33) | Abstract References ORCID License | 60.21 | 3 |
| 31 | LYMPHOPENIA: THE MAIN CAUSES (10.20514/2226-6704-2016-6-2-22-27) | Abstract References ORCID License | 60.21 | 3 |
| 32 | MITRAL VALVE PROLAPSE AND SUDDEN CARDIAC DEATH: WHO IS IN TH… (10.20514/2226-6704-2016-6-3-25-29) | Abstract References ORCID License | 60.21 | 3 |
| 33 | THE COURSE OF DISSECTING ANEURYSM OF THE AORTA (10.20514/2226-6704-2016-6-3-68-70) | Abstract References ORCID License | 60.21 | 3 |
| 34 | DIFFICULTY OF COPD PREDICTING AS A CHALLENGE TO MODERN CLINI… (10.20514/2226-6704-2016-6-4-14-20) | Abstract References ORCID License | 60.21 | 3 |
| 35 | THE PECULIARITIES OF CLINICAL PROGRESSION OF GASTRODUODENAL… (10.20514/2226-6704-2016-6-4-30-35) | Abstract References ORCID License | 60.21 | 3 |
| 36 | ACUTE CHOLANGITIS, COMPLICATED BY BILIARY SEPSIS: CLINICAL C… (10.20514/2226-6704-2016-6-4-65-69) | Abstract References ORCID License | 60.21 | 3 |
| 37 | MODERN VIEW OF CARDIOPULMONARY EXERCISE TESTING (REVIEW OF A… (10.20514/2226-6704-2017-7-1-5-14) | Abstract References ORCID License | 60.21 | 3 |
| 38 | SILVER NANOPARTICLES IN THE SOLUTION OF THE PROBLEM OF DRUG… (10.20514/2226-6704-2017-7-3-188-199) | Abstract References ORCID License | 60.21 | 3 |
| 39 | MINERAL DENSITY AND METABOLISM OF BONE TISSUE IN PATIENTS WI… (10.20514/2226-6704-2017-7-3-205-211) | Abstract References ORCID License | 60.21 | 3 |
| 40 | PATIENTS WITH ATRIAL FIBRILLATION AND ISCHEMIC HEART DISEASE… (10.20514/2226-6704-2017-7-3-217-223) | Abstract References ORCID License | 60.21 | 3 |
| 41 | EVALUATION OF LABOR CONDITIONS BY PUBLIC HEALTH WORKERS IN T… (10.20514/2226-6704-2018-8-2-127-136) | Abstract References ORCID License | 60.21 | 3 |
| 42 | Cardiorenal syndrome in patients with heart failure as a sta… (10.20514/2226-6704-2019-9-2-93-106) | Abstract ORCID | 57.31 | 13 |
| 43 | STATIN ADVERSE EFFECTS: MECHANISMS, DIAGNOSIS, PREVENTION AN… (10.20514/2226-6704-2018-8-4-266-276) | ORCID License | 50.00 | 9 |
| 44 | Pro-inflammatory cytokines in patients with chronic kidney d… (10.20514/2226-6704-2019-9-6-428-433) | Abstract ORCID | 50.00 | 9 |
| 45 | REVIEW OF RECOMMENDATIONS FOR THE MANAGEMENT OF POLYMYALGIA… (10.20514/2226-6704-2016-6-1-3-5) | Abstract References ORCID License | 47.71 | 2 |
| 46 | EFFECTIVE TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE A… (10.20514/2226-6704-2016-6-1-54-62) | Abstract References ORCID License | 47.71 | 2 |
| 47 | HEPATOCELLULAR CARCINOMA. RECENT ADVANCES IN DIAGNOSIS AND T… (10.20514/2226-6704-2016-6-1-63-69) | Abstract References ORCID License | 47.71 | 2 |
| 48 | TTV-INFECTION: CLINICAL, EPIDEMIOLOGICAL AND DIAGNOSTIC ASPE… (10.20514/2226-6704-2016-6-2-28-33) | Abstract References ORCID License | 47.71 | 2 |
| 49 | BRUGADA SYNDROME: FROM PRIMARY ELECTRIC HEART DISEASE TO MOR… (10.20514/2226-6704-2016-6-2-61-69) | Abstract References ORCID License | 47.71 | 2 |
| 50 | DIAGNOSTIC SIGNIFICATION OF EXANTHEMA IN THE PREHOSPITAL CAR… (10.20514/2226-6704-2016-6-3-36-41) | Abstract References ORCID License | 47.71 | 2 |